Results
1
-
2
of
2
[DOI: 10.1016/j.bmc.2007.01.057]
A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate
,
European Journal of Clinical Pharmacology
[DOI: 10.1007/s00228-002-0539-1]